A randomized controlled study on the analgesic treatment of migraine in acute phase with the combination of horizontal penetration needling and rizatritan

anjing Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1) Meet the diagnostic criteria of migraine without aura and migraine with aura;
•2) Aged 18-50 years, with a history of migraine for more than 12 months;
•3) In the acute phase, the pain degree was evaluated by visual analogue scale (VAS) method with 4 points or more;
•4) Patients voluntarily received relevant acute analgesia treatment and signed informed consent.

•1) Patients with hypertension and current unstable blood pressure control (stage 2, high-risk patients and above), coronary heart disease (including patients with pacemakers), cerebral infarction and other cardiovascular and cerebrovascular stenosis or obstructive diseases, peripheral vascular stenosis and obstruction;
•2) Patients with severe primary diseases such as liver, kidney, digestion and blood system;
•3) Mental patients, or patients with infection and bleeding;
•4) Pregnant or lactating women;
•5) Patients with organic lesions;
•6) Patients who cannot understand and cooperate with the visual analogue scale (VAS) method.

发起方

anjing Hospital of Traditional Chinese Medicine